(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors

Clinical trial NCT02508532 · COMPLETED

Trial details

NCT number: NCT02508532
Sponsor: Blueprint Medicines Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors (GIST)Other Relapsed or Refractory Solid Tumors

Start date: 2015-08-01
Primary completion: 2020-03-06
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.